SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40
0 references·16 citing·47 second hop
Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998)Cost effectiveness analysis of improved b…Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008? (2020)Cost-effectiveness of Interve…Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes (2008)Cost-Effectiveness of Intensi…Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation (2006)Using and interpreting cost-e…Statistical Analysis of Cost‐effectiveness Data (2006)Statistical Analysis of Cost‐…Need for differential discounting of costs and health effects in cost effectiveness analyses (2005)Need for differential discoun…Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72) (2005)Cost-utility analyses of inte…Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis (2004)Screening for Type 2 Diabetes…Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models (2004)Assessing generalisability by…The impact of diabetes‐related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65) (2003)The impact of diabetes‐relate…Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies (2003)Advantages of Using the Net-B…El coste de la diabetes tipo 2 en España. El estudio CODE-2 (2002)El coste de la diabetes tipo …The methodologic partnership of effectiveness reviews and cost-effectiveness analysis (2001)The methodologic partnership …Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses (2001)Quantifying stochastic uncert…Direct medical costs for patients with type 2 diabetes in Sweden (2000)Direct medical costs for pati…Definition, interpretation and calculation of cost-effectiveness acceptability curves (2000)Definition, interpretation an…A Bayesian approach to stochastic cost-effectiveness analysis (1999)A Bayesian approach to stocha…Costs, effects and C/E‐ratios alongside a clinical trial (1994)Net Health Benefits (1998)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope (2006)Economic evaluation of a task-shifting intervention for common mental disorders in India (2012)Health economic evaluation: Important principles and methodology (2013)Measurement of health state utilities for economic appraisal (1986)National Institute for Clinical Excellence and its value judgments (2004)Utilities and disutilities for type 2 diabetes treatment-related attributes (2007)Utilities and disutilities for attributes of injectable treatments for type 2 diabetes (2010)Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study (2015)The Economics of Welfare (1933)Cost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Discounting and decision making in the economic evaluation of health-care technologies (2010)Handleiding voor kostenonderzoek: methoden en referentieprijzen voor economische evaluaties in de gezondheidszorg (2012)UPDATE OF THE DUTCH MANUAL FOR COSTING IN ECONOMIC EVALUATIONS (2012)Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications Trial (1996)Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes (2002)Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults (2007)Screening Adults for Pre-Diabetes and Diabetes May Be Cost-Saving (2010)Economic Consequences of Diabetes Mellitus in the U.S. in 1997 (1998)A Comparison of United Kingdom and Spanish General Population Time Trade-off Values for EQ-5D Health States (2001)Direct Health Care Costs of Diabetic Patients in Spain (2004)Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain (2005)Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain (2015)Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane (1998)Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods (2002)Non‐parametric methods for cost‐effectiveness analysis: the central limit theorem and the bootstrap compared (2009)Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation (1997)BAYESIAN VALUE-OF-INFORMATION ANALYSIS (2001)Incremental cost-effectiveness ratios (ICERs): The silence of the lambda (2005)Regression models for analyzing costs and their determinants in health care: an introductory review (2011)Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998)Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) (2000)Event Rates, Hospital Utilization, and Costs Associated with Major Complications of Diabetes: A Multicountry Comparative Analysis (2010)Diabetes expenditure, burden of disease and management in 5 EU countries (2012)The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84) (2014)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Economic Costs of Diabetes in the U.S. in 2002 (2003)Economic Costs of Diabetes in the U.S. in 2017 (2018)Utility approach to measuring health-related quality of life (1987)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial (2009)Health Economic Methods: Cost-Minimization, Cost-Effectiveness, Cost-Utility, and Cost-Benefit Evaluations (2011)Probabilistic sensitivity analysis in health economics (2011)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2000Definition, interpretation and calculation of cost-effectiveness acceptability curves292 cited
  • 2006Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation279 cited
  • 1999A Bayesian approach to stochastic cost-effectiveness analysis253 cited
  • 2003The impact of diabetes‐related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65)246 cited
  • 2005Need for differential discounting of costs and health effects in cost effectiveness analyses225 cited
  • 2004Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis178 cited
  • 2020Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?164 cited
  • 2006Statistical Analysis of Cost‐effectiveness Data155 cited
  • 2005Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72)155 cited
  • 2002El coste de la diabetes tipo 2 en España. El estudio CODE-2154 cited
  • 2000Direct medical costs for patients with type 2 diabetes in Sweden153 cited
  • 2001The methodologic partnership of effectiveness reviews and cost-effectiveness analysis150 cited
  • 2008Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

147 cited
  • 2003Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies124 cited
  • 2004Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models117 cited
  • 2001Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses112 cited